Evidence map›Paper›PMID 40312352›Full record

ArticleMicrobial cell factories2025

Probiotic spore-based antigen delivery: a novel oral vaccine strategy against Vibrio infections in aquaculture.

Marina De Stefano, Giovanni Di Gregorio Barletta, Simona Morgera, Ylenia De Luca, Chiara Belaeff, Karen Power, Loredana Baccigalupi, Gionata De Vico, Ivan Conte, Ezio Ricca and 1 more

Abstract read
In one paragraph

Article in Microbial cell factories, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Marina De Stefano *Dipartimento di Biologia, Università di Napoli Federico II, Naples, Italy.
Giovanni Di Gregorio Barletta *Dipartimento di Biologia, Università di Napoli Federico II, Naples, Italy.
Simona MorgeraDipartimento di Biologia, Università di Napoli Federico II, Naples, Italy.
Ylenia De LucaDipartimento di Biologia, Università di Napoli Federico II, Naples, Italy.
Chiara BelaeffDipartimento di Biologia, Università di Napoli Federico II, Naples, Italy.
Karen PowerDipartimento di Biologia, Università di Napoli Federico II, Naples, Italy.
Loredana BaccigalupiDipartimento di Medicina Molecolare e Biotecnologie Mediche, Università di Napoli Federico II, Naples, Italy.
Gionata De VicoDipartimento di Biologia, Università di Napoli Federico II, Naples, Italy.
Ivan ConteDipartimento di Biologia, Università di Napoli Federico II, Naples, Italy.
Ezio RiccaDipartimento di Biologia, Università di Napoli Federico II, Naples, Italy. ericca@unina.it.
Anella SaggeseDipartimento di Biologia, Università di Napoli Federico II, Naples, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundVibriosis is a deadly illness caused by various species of the Vibrio genus. Due to its high incidence in aquaculture plants, vibriosis is responsible for significant economic losses. Currently, anti-vibriosis treatments rely on antibiotics. However, the global rise in antibiotic resistance necessitates the development of alternative approaches. Novel vaccines and effective probiotics have been proposed as potential alternative to antibiotics in fighting bacterial infections. Here we propose a combined vaccine/probiotic strategy based on the use of probiotic bacterial spores for the oral delivery of Vibrio antigens. Spores of various species of the Bacillus genus are widely used as probiotics and have been shown to efficiently display antigens in a non-recombinant way.

resultsSpores of various probiotic strains were analyzed to assess their effectiveness in displaying a heterologous model protein, and B. megaterium MV30 was identified as the most efficient strain. MV30 spores were then used to display two antigens of Vibrio harveyi, the entire Hsp33 protein of 33 kDa and a 239 amino acids fragment of OmpK (OmpK

conclusionOur results support the use of probiotics and oral vaccines as a valid alternative to antibiotics and point to the application of probiotic spore-based antigen delivery as a novel strategy to fight pathogenic infections.

Indexed as

Antigens, BacterialBacterial VaccinesFish DiseasesProbioticsSpores, BacterialVibrioVibrio InfectionsAdministration, OralAnimalsAquacultureBacillusAntigens, BacterialBacterial VaccinesBacillusDelivery systemGutMucosal adjuvantMucosal vaccine

Identifiers

PMID40312352
PMCPMC12046727

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.